分类： ACN Newswire

香港, 2025年8月22日 - (亚太商讯 via SeaPRwire.com) – 近年来，人工智能与高性能计算的快速发展，以及新能源汽车和智能驾驶产业加速渗透，推动着PCB（印制电路板）行业进入新一轮高景气周期。作为承载核心计算组件的关键载体，高端PCB正成为科技企业抢占未来制高点的战略支撑。在这一领域，胜宏科技（惠州）股份有限公司（「胜宏科技」）凭借领先技术、高质量产品和行业领先产能优势，已成长为全球高端PCB的领军者。根据弗若斯沙利文的资料，以2025年第一季度人工智能算力PCB收入规模计，胜宏科技市场份额位居全球第一。8月20日，胜宏科技向港交所递交上市申请，拟通过「A+H」两地资本市场布局，为下一阶段的跨越式发展蓄力。核心技术壁垒 铸就全球高端PCB领导者胜宏科技的核心竞争力，来自其在高端PCB领域构筑的深厚技术壁垒。公司以全链条创新体系为支撑，覆盖技术研发、工艺优化到量产应用的全流程环节，并围绕支撑AI算力的关键PCB技术路线，在工艺技术、制造技术和材料创新等方面提前进行技术储备和攻关，持续夯实竞争壁垒。胜宏科技作为PCB行业技术引领者，经过前瞻性技术布局，公司具备生产100层以上高多层PCB制造能力，70层以上高多层PCB量产能力，是全球首批实现6阶24层HDI产品大规模生产，以及8阶28层HDI与16层任意互联（Any-layer）HDI技术能力的企业，并能够支持PCIe6.0、1.6T 光模块等新一代前沿通信技术。公司应用于Eagle/Birch Stream/Turin平台服务器领域的产品均已实现批量化生产，下一代Oak Stream/Venice平台服务器也已进入测试阶段。在算力和 AI 服务器领域，胜宏科技是全球首批实现6阶24层HDI大规模量产的企业，并已启动10阶30层HDI研发认证，线宽/线距已突破至40/40μm；其100层以上产品技术研发储备亦远超行业平均水平。在材料创新方面，胜宏科技已完成M7及M8级材料在产品中的电性能和热性能验证，并推进M9级材料认证，支持224Gbps高速传输，为AI服务器及交换机的升级做好了充分准备。凭借领先的研发成果、规模化产能与国际化交付体系，胜宏科技成为众多全球顶尖科技企业的重要合作伙伴。在AI算力卡、AI Data Center UBB &交换机领域，胜宏科技市场份额全球领先，成为行业不可替代的供应商。卡位AI与智能驾驶黄金赛道 打开成长天花板凭借研发技术优势、制造技术优势和质量技术优势，胜宏科技实现大规模量产，推动业绩高速增长。2022年至2024年，公司收入从人民币78.85亿元增至107.31亿元，利润从7.91亿元增至11.54亿元，复合年增长率分别为16.7%及20.8%，进入2025年，胜宏科技延续强劲增长，一季度收入同比大增80.3%，利润同比飙升339.2%，盈利能力进一步跃升。从行业维度来看，人工智能与高性能计算、智能终端、汽车电子、网络通信等行业的不断升级，正驱动PCB市场正迎来结构性增长机遇，高端PCB需求快速攀升。在AI领域，技术迭代和应用落地引爆算力需求。根据弗若斯特沙利文的资料，预计到2029年全球人工智能及高性能计算PCB市场规模将增至150亿美元，2024-2029年复合年增长率达到20.1%。在汽车电子领域，新能源汽车与智能驾驶加速渗透，同样推升高性能PCB需求。预计到2029年，全球汽车电子PCB市场规模将增至111亿美元，其中，14层及以上高多层PCB市场规模预计达12.0亿美元，2024-2029年复合增长率达8.1%； 高阶HDI市场规模预计达9.0亿美元，2024-2029年年复合增长率达8.6%。作为深耕高端PCB的全球领导者，胜宏科技凭借技术领先2-3年的量产实力、全球第一的市场份额以及在AI算力与新能源汽车赛道的前瞻布局，已成为产业升级的核心受益者。随着行业规模的持续扩容，公司领先的市场份额有望进一步放大。此外，公司还在智慧终端机、5G通信及高端医疗等领域积极布局，拓展新的成长空间。伴随着多元应用场景进入升级周期，胜宏科技的成长动能与业绩释放潜力将持续增强。此次递表港交所，藉助香港这一国际金融中心的资本与流动性优势，胜宏科技有望进一步拓宽融资管道，提升全球资本市场的认可度和透明度；另一方面，H股平台将帮助公司加快海外产能布局，提升与国际客户的战略协同，进一步夯实其全球化竞争优势。随着AI与新能源产业的持续爆发，胜宏科技有望在「技术创新+资本赋能」的双轮驱动下，进一步夯实全球领导地位，并持续释放长期成长价值。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 22, 2025 - (ACN Newswire via SeaPRwire.com) - Everbright Grand China Assets Limited ("Everbright Grand China" or the "Group"; HKEX stock code: 03699.HK), a subsidiary of China Everbright Group, principally engaged in the businesses of property leasing, property management and the sales of properties held for sale, announced its interim results for the six months ended 30 June 2025 ("Reporting Period").During the Reporting Period, revenue of the Group was approximately RMB24.5 million,  representing an increase of approximately RMB0.6 million as compared with 2024. Profit attributable to equity shareholders was approximately RMB10.1 million, representing a decrease of approximately RMB1.3 million as compared with 2024, mainly attributable to the increase in the PRC income tax and deferred taxation. Gross profit was approximately RMB18.1 million, representing an increase of approximately RMB0.6 million as compared with 2024. Basic earnings per share of the Group was approximately RMB2.30 cents (2024: RMB2.59 cents). The Board declared an interim dividend of RMB0.73 cents (equivalent to HK0.80 cents) per ordinary share.Considering that the current operating environment remains relatively challenging, the Board declared an interim dividend of RMB0.73 cents (equivalent to HK0.80 cents) per ordinary share, as a token of appreciation to shareholders for their continuous support. In the second half of the year, the Company will decide on dividend distribution taking into account factors such as business development needs, financial performance and capital position, as well as performance growth, in order to bring the best return to the Company's shareholders and investors.In 2025, global economic environment continues to be characterized by uncertainties. Factors such as geopolitical risks, inflationary pressures and monetary policy adjustments in major economies around the world continue to affect market confidence and capital flows. Nevertheless, the overall stability of China’s economy, the gradual rebound of the consumer market and the continued optimization and upgrading of the industrial structure have provided a solid foundation for the development of the property management and leasing industry.For the six months ended 30 June 2025, the Group generated rental income of approximately RMB17.0 million (2024: RMB16.3 million), representing an increase of approximately RMB0.7 million as compared to the same period last year. The Company’s properties maintained an occupancy rate of approximately 81%, with the overall leasing market performing solidly, although newly signed rents declined compared to the previous period. In the face of downward pressure on rents, the Group will enhance its consolidated earning power by adding additional services to new leases to mitigate the impact of lower rents on overall revenue. This not only enriches the service offerings, but also helps to enhance customer stickiness and satisfaction, further consolidating the Group’s market competitiveness.During the period, revenue from the property management services was approximately RMB7.5 million (2024: RMB7.6 million), representing a decrease of approximately RMB0.1 million as compared to the same period last year. In terms of property portfolio strategy, the Group actively promotes tenant diversification to mitigate industry risks and adapt to the accelerated rise and fall of market environment of various industries. The Group’s existing properties are mainly concentrated in two core cities of Chengdu in Sichuan Province and Kunming in Yunnan Province, covering three commercial buildings, namely Everbright Financial Center, Everbright International Mansion and Ming Chang Building, with a total gross floor area of approximately 89,507 square meters. Benefiting from its excellent geographical location and sound property quality, it has attracted a large number of state-owned enterprises and large organizations to move in and has a solid leasing base. In the future, the Group will promote business diversification to enhance its overall risk-resistant capability.In terms of overseas investment, the Group is evaluating investment opportunities in international markets and is cautiously optimistic about overseas markets. Notwithstanding the volatility of the global economy, the Group will adhere to the principle of prudence and flexibility in its investment horizon to ensure the safety and profitability of its capital operations.As at 30 June 2025, The Group maintained cash and bank balances and bank deposits of approximately RMB236.2 million (31 December 2024: RMB231.5 million). The Group’s gearing ratio, being measured by the Group’s total liabilities over its total assets, was 18.6% (31 December 2024: 18.0%). The Group’s liquidity position was well-managed.Looking ahead to the second half of 2025, there are no new property management projects for the time being, despite favourable lease performance in the first half of the year. The Group is actively looking for suitable investment windows for its acquisition and investment plans which were delayed during the epidemic. With the active domestic economy and falling interest rates, the market’s willingness to invest has increased significantly.The Group will continue to deepen its digital transformation and actively utilize technology to promote the construction of intelligent properties and enhance operational efficiency and customer experience. Through technological empowerment, we optimize the allocation of human resources and service processes, enhance the level of intelligence and refinement of property management, and improve overall service quality and customer satisfaction.In addition, the Group will fully utilize the synergies with its parent company, China Everbright Group, and leverage on the popularity of the “Everbright” brand and its resource advantages to actively develop diversified value-added services, enrich its revenue structure and enhance its brand influence. In the face of industry restructuring and upgrading, the Group insists on stable operation, focuses on risk management and internal control, responds flexibly to changes in the macro-economy and policies, and continues to optimize its asset portfolio in order to enhance its risk-resistant capability. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年8月22日 - (亚太商讯 via SeaPRwire.com) - 光大永年有限公司，为中国光大集团旗下物业租赁、及物业管理及销售持作出售物业公司（「光大永年」或「集团」，香港联交所股份代号：03699.HK）今天公布截至2025年6月30日止（「报告期内」）之中期业绩。报告期内，集团的收益约为人民币24.5百万元（2024年：人民币23.9百万元），较去年同期增加约人民币0.6百万元，主要由于租赁收入增加所致。本公司权益股东应占溢利约为人民币10.1百万元（2024年：人民币11.4百万元），较去年同期减少约人民币1.3百万元，乃主要由于中国所得税及递延税项增加所致。集团录得毛利约人民币18.1百万元（2024年：人民币17.5百万元），较去年同期增加约人民币0.6百万元。每股基本盈利约为人民币2.30分（2024年：人民币2.59分）。考虑到目前经营环境仍是面对比较大挑战的情况下，董事会宣布派发截至2025年6月30日止六个月之本公司中期股息每股普通股人民币0.73分（相当于0.80港仙）（2024年：人民币0.78分（相当于0.85港仙）），以答谢股东一直以来的支持。2025年，全球经济环境依然充满不确定性，地缘政治风险、通胀压力及全球主要经济体货币政策调整等因素持续影响市场信心和资本流动。尽管如此，中国经济保持总体稳定，消费市场逐步回暖，产业结构持续优化升级，为物业管理及租赁行业提供了稳健的发展基础。截至2025年6月底，本集团的租金收入约为人民币17.0百万元（2024年： 人民币16.3百万元），较去年同期增加约人民币0.7百万元，旗下物业出租率维持在约81%（2024年：77%），整体租赁市场表现稳健，但新签订租金水平较此前有所下降。面对租金下调压力，本集团将通过在新租约中增加附加服务，提升综合收益能力，缓解租金下降对整体收入的影响。此举不仅丰富了服务内容，也有助于增强客户粘性和满意度，进一步巩固本集团的市场竞争力。物业管理服务的收益约为人民币7.5百万元（2024年：人民币7.6百万元），较去年同期下降约人民币0.1百万元。在物业组合策略方面，本集团积极推动租户多元化，分散行业风险，适应各行业兴衰加速的市场环境。本集团现有物业主要集中于四川成都和云南昆明两大核心城市，涵盖光大金融中心、光大国际大厦及明昌大厦三栋商业楼宇，总建筑面积约89,507平方米。得益于优越的地理位置和良好的物业质量，吸引了大量国有企业及大型机构入驻，租赁基础稳固。未来，本集团将推动业务多元化发展，提升整体抗风险能力。海外投资方面，本集团正评估国际市场的投资机会，体现出对海外市场的审慎乐观态度。尽管当前全球经济波动较大，本集团将坚持稳健原则，灵活把握投资窗口，确保资本运作的安全性和收益性。于2025年6月30日，本集团持有现金及银行结余以及银行存款约为人民币236.2百万元（2024年12月31日：人民币231.5百万元）。资本负债比率（按本集团总负债除以总资产计量）为18.6%（2024年12月31日：18.0%）。本集团的流动资金状况良好。展望2025年下半年，尽管上半年租约表现良好，但暂无新增物业管理项目。疫情期间延迟的收购及投资计划，随着国内经济活跃和利率下调，市场投资意愿明显增强，本集团正积极寻找合适的投资窗口。本集团将继续深化数字化转型，积极运用科技，推动智慧物业建设，提升运营效率和客户体验。通过技术赋能，优化人力资源分配和服务流程，增强物业管理的智慧化和精细化水平，提升整体服务质量和客户满意度。此外，本集团将充分发挥与母公司中国光大集团的协同效应，借助"光大"品牌的知名度和资源优势，积极拓展多元化增值服务，丰富收入结构，提升品牌影响力。面对行业转型升级，本集团坚持稳健经营，注重风险管理和内部控制，灵活应对宏观经济及政策变化，持续优化资产组合，增强抗风险能力。 Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年8月22日 - (亚太商讯 via SeaPRwire.com) - 中联发展控股集团有限公司（下称「本公司」；联交所编号：0264）欣然宣布，已签订最终协议收购香港金融科技创新企业 - NVTHK有限公司（「NVT」）20%股权。NVT为现实资产（「RWA」）代币化市场的先行者。通过本次战略性收购，公司已站在一个有望重塑全球资本市场，并于未来数年实现高速增长的行业前沿。NVT - 开创性市场先行者NVT是香港领先的RWA代币化基础设施提供商，通过其强大的OTC平台，构建了行业首个可支持顶级金融机构一级发行和受监管代币化资产链上二级交易的完整生态系统。其高度整合的封闭式平台，连接资产发行人、投资者及流动性提供者，为金融业带来前所未有的效率及流动性。NVT拥有享誉盛名的机构级客户阵容，涵盖顶尖金融机构、资产管理人及Web3创新企业，包括信达国际资管、广发证券、金洲资产管理、Animoca Brands及HashKey Group。现时平台支援多类型金融产品的代币化发行，如货币市场基金、结构性产品、债券及私募股权基金，展现其广泛应用及市场认可度。此次收购对中联发展控股的战略意义根据波士顿咨询集团（BCG）于2025年4月发布的报告，全球RWA代币化市场预计将由2025年的0.6万亿美元在中位情景下增长至2033年的18.9万亿美元，年均复合增长率达53%。该行业的快速扩张反映了机构及零售投资者对高收益、透明且易于直接投资的资产类别的需求日益增加。透过收购NVT 20%股权，本公司将获得：- 经验丰富且全面合规的一站式机构级代币化平台；- 独家接入香港首个可在链上OTC市场进行二级交易的RWA生态系统；- 已建立的全球分销网络 - 迅速连接流动性提供者、资产发行人及投资者；- 与行业领袖伙伴携手进一步建立市场公信力及拓展市场触及范围。本次收购大幅加速公司进军高速增长的RWA市场，无需承担从零自建平台所带来的延误、风险与资本开支。该收购亦符合本公司致力于探索创新与新业务机会，以实现收入多元化的承诺。战略合作领域在此次投资完成后，公司与NVT将于两大战略范畴展开合作：皮革生产及供应链RWA代币化依托NVT平台，本公司将率先于全球推动皮革行业实体及无形资产（包括现金流、应收帐款、存货及知识产权等）的代币化，实现营运资金释放、开拓新投资渠道、自动化结算并拓展全球流动性。拓展新的RWA垂直领域双方将共同开发并规模化推进其他行业的RWA解决方案，结合本公司产业专长与NVT经验验证的基础设施，把握多元资产类别中的潜在机遇。中联发展控股集团有限公司行政总裁赵靖飞表示："本次投资NVT代表着公司跨越性发展的重要一步。NVT作为行业先行者及领导者，结合独有链上一级及二级交易能力及卓越客户基础，令我们可深度参与万亿级增长机遇，加速核心业务数码化并创造长远股东价值。"NVT创办人兼行政总裁赵建公表示："我们的使命是运用区块链技术重新定义资本市场，特别聚焦于亚洲金融中心 — 香港。通过与中联发展的合作，我们将来自实体产业的优质资产引入并无缝对接至资本市场。此次合作不仅进一步强化了我们的平台实力，也为我们的合作伙伴生态系统创造了可观的价值增长机遇，同时明确聚焦于为股东实现长期回报最大化。我们所构建的仅仅是一个开始 — 在未来，全新的商业模式、创新的资产类别以及可扩展的增长潜力将展现出无限可能。"关于NVTNVTHK有限公司（「NVT」）为总部位于香港的金融科技创新企业，专注现实资产（RWA）代币化基础设施、虚拟资产经纪系统及稳定币技术方案。NVT 为香港首家通过 OTC 平台实现受监管代币化资产链上交易的企业，为发行人、投资者及中介机构提供企业级技术解决方案。关于中联发展控股集团有限公司中联发展控股集团有限公司（「CIDC」）于开曼群岛注册成立，并于香港联合交易所主板上市（股份代号：0264）。作为一家成熟的投资控股公司，CIDC 在高品质皮革制品的制造与分销方面建立了坚实基础。CIDC 积极推动创新与转型战略，寻求突破传统核心业务的更多机遇。公司始终致力于寻找新业务与价值创造的契机，并适时扩展经营范畴与投资版图。传媒垂询：NVTHK有限公司梁海燕   电话:2522 3869 电邮: Olivia.leung@newvisiongp.com 网址: www.nvt.cim.hk Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 22, 2025 - (ACN Newswire via SeaPRwire.com) - China International Development Corporation Limited (“the Company”; SEHK: 0264) is pleased to announce that it has entered into a definitive agreement to acquire a 20% equity interest in NVTHK Ltd. (“NVT”), a Hong Kong-based financial technology innovator and first mover in the Real-World Asset (“RWA”) tokenization market. This strategic acquisition positions the Company at the forefront of a sector expected to reshape global capital markets and deliver exponential growth in the years ahead.NVT — First Mover in a Transformative MarketNVT is the pioneering RWA tokenization infrastructure provider in Hong Kong, uniquely enabling primary issuance from top-tier financial institutions and on chain secondary trading of regulated tokenized assets through its robust OTC market place — the first full-scale ecosystem of its kind in the market.Its fully integrated, closed-loop ecosystem connects asset issuers, investors, and liquidity providers, unlocking unprecedented efficiency and liquidity for the financial industry.NVT’s prestigious institutional-grade clientele spans top financial institutions, asset managers, and Web3 innovators, including Cinda Asset Management, GF Securities, Golden Continent Asset Management, Animoca Brands, and HashKey Group. Its platform currently supports tokenized issuances across multiple financial product categories — including money market funds, structured products, bonds, private equity funds—demonstrating broad applicability and market acceptance.This Acquisition is Breakthrough for China International DevelopmentAccording to a BCG report dated April 2025, the global RWA tokenization market is forecast to grow from US$0.6 trillion in 2025 to US$18.9 trillion by 2033 in the midpoint scenario — a 53% compound annual growth rate. The sector’s rapid expansion reflects rising institutional and retail demand for high yield, transparent, and directly accessible asset classes.By acquiring a 20% stake in NVT, the Company gains:- A turnkey, proprietary institutional-grade tokenization platform — success-proven and fully regulated;- Access to the first RWA ecosystem in Hong Kong with secondary trading via an on chain OTC marketplace;- An established global distribution network with instant connectivity to liquidity providers, asset issuers, and investors globally;- Credibility and market access through alignment with a trusted RWA ecosystem serving blue chip clients.This acquisition accelerates the Company’s entry into the high growth RWA market at scale, without the delays, risks, and capital expenditure associated with building a platform from scratch. The Acquisition is also consistent with the Company’s commitments to exploring innovations and new business opportunities to diversify income streams.Strategic Collaboration AreasFollowing the investment, the Company and NVT will collaborate in two strategic areas:RWA Tokenization in Leather Production & Supply ChainLeveraging NVT’s platform, the Company will be a global first mover in tokenizing tangible and intangible assets within the leather industry—such as cash flows, receivables, inventory, and IP. This will unlock working capital, open new investment channels, automate settlements, and expand liquidity access worldwide.Expansion into New RWA VerticalsTogether, the Company and NVT will develop and scale RWA tokenization solutions for other industries, deploying the Company’s sector expertise and NVT’s proven infrastructure to capture untapped opportunities in multiple asset classes.Zhao Jingfei, CEO of China International Development Corporation Limited said:“This investment in NVT represents a breakthrough for our Company. NVT’s unmatched first mover position, its proven track record with prestigious institutional clients, and its unique on chain secondary trading capabilities place it in a category of its own. We are now positioned to participate meaningfully in a trillion dollar growth opportunity while modernizing our core business and delivering long term shareholder value.”Jay Zhao, the founder and CEO of NVT added:“Our mission is to leverage blockchain technology to redefine capital markets, with a particular focus on Hong Kong — the financial hub of Asia. By partnering with China Development, we are opening access to high quality assets from real-world industries and seamlessly integrating them into the capital market. This partnership not only enhances the strength of our platform but also creates significant opportunities for value creation across our ecosystem of partners, with a clear focus on maximizing long term shareholder returns. What we are building is just the beginning — the potential for new business models, innovative asset classes, and scalable growth ahead is truly limitless.”About NVTNVTHK Limited. (“NVT”) is a Hong Kong based fintech innovator specializing in real world asset (RWA) tokenization infrastructure, virtual asset brokerage systems, and stablecoin technology solutions. NVT is the first in Hong Kong to enable regulated tokenized assets to be traded on chain through its OTC marketplace, offering enterprise grade technology for issuers, investors, and intermediaries.About China International Development Corporation LimitedChina International Development Corporation Limited (“CIDC”) was incorporated in the Cayman Islands and is listed on the Main Board of The Stock Exchange of Hong Kong under stock code 0264. As an established investment holding company, CIDC has built a strong foundation in the manufacturing and distribution of high-quality leather products.  CIDC has proactively embarked on a strategy of innovation and transformation, seeking opportunities beyond its traditional core business. The Company is always committed to seeking opportunities for new business and value creation, as well as for timely expansion of the Company’s scope of operation and investments.For press enquiries:NVTHK LimitedOlivia Leung   Tel: 2522 3869 Email: Olivia.leung@newvisiongp.comWebsite: www.nvt.cim.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - August 21, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that as a result of strong investor demand, the Company has increased the size of its previously announced "bought deal" public offering (the "Underwritten Offering") from gross proceeds of approximately C$5,000,000 to gross proceeds of approximately C$6,000,000. Pursuant to the upsized Underwritten Offering, Red Cloud Securities Inc. ("Red Cloud"), as sole underwriter and bookrunner, has agreed to purchase for resale 6,666,667 units of the Company (each, a "Unit") at a price of C$0.90 per Unit (the "Offering Price").Each Unit will consist of one common share of the Company (each, a "Unit Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant shall entitle the holder to purchase one common share of the Company (each, a "Warrant Share") at a price of C$1.35 at any time on or before that date which is 36 months after the Closing Date (as herein defined).The Company has granted to the Underwriter an option (the "Over-Allotment Option", and together with the Underwritten Offering, the "Offering"), exercisable, in whole or in part, at any time for a period of up to 30 days after and including the Closing Date, to purchase for resale the number of additional Units equal to up to 15% of the number of Units sold pursuant to the Underwritten Offering at the Offering Price to cover over allotments, if any, and for market stabilization purposes.The net proceeds from the Offering will be used by the Company to fund ongoing operations including, but not limited to, commercial development, product development and working capital.In connection with the Offering, the Company intends to file a prospectus supplement (the "Supplement") to the Company's final short form base shelf prospectus dated March 7, 2025 (the "Shelf Prospectus"), with the securities regulatory authorities in each of the provinces and territories of Canada, except Quebec. The Units may also be sold in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and in such other jurisdictions outside of Canada and the United States, in each case in accordance with all applicable laws provided that no prospectus, registration statement or similar document is required to be filed in such jurisdiction, and provided the issuance of the Units (including the underlying securities) is permitted under laws applicable to the Company (including the Australian Corporations Act 2001 (Cth).Copies of the Shelf Prospectus and the Supplement to be filed in connection with the Offering, can be found on SEDAR+ at www.sedarplus.ca. The Shelf Prospectus contains, and the Supplement will contain, important detailed information about the Company and the Offering. Prospective investors should read the Supplement, the Shelf Prospectus and the other documents the Company has filed on SEDAR+ at www.sedarplus.ca before making an investment decision.The Offering is expected to close on or about September 3, 2025 (the "Closing Date"), or on such date as agreed upon between the Company and Red Cloud. The closing of the Offering is subject to the Company receiving all necessary regulatory approvals, including the approval of the TSX Venture Exchange to list, on the Closing Date, the common shares of the Company issuable from the sale of Units as well as upon the exercise of the Warrants.This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.About GMGGMG is an Australian-based clean-technology company, which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in-house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low-cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy saving coating), which is now being marketed into other applications, including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium ion batteries.GMG's 4 critical business objectives are:Produce Graphene and Improve/Scale Cell Production ProcessesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the expected size and terms of the Offering, the anticipated timing of closing the Offering, the ability of the Company to satisfy all conditions to closing the Offering, and the expected use of proceeds from the Offering.Such forward-looking statements are based on a number of assumptions of management, including, without limitation, expectations and assumptions concerning the business objectives of the Company; the Company's ability to carry out current planned capital projects, research and development, manufacturing, production, sales and marketing programs for its graphene and graphene-enhanced products and solutions; that the Company will receive the necessary regulatory approvals for the Offering; use the proceeds from the Offering as anticipated; the Company's performance and general business and economic conditions.Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: the risk that the Company is not able to use the proceeds from the Offering as anticipated by management; the risk that the Company does not receive the requisite regulatory approvals for the Offering; overall economic conditions; technical de-risking and market acceptance for the Company's products and solutions; the introduction of competing technologies or products; stock market volatility; environmental and regulatory requirements; competitive pressures; change in market conditions and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied in these forward-looking statements; the volatility of global capital markets; political instability; the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel; unexpected development and production challenges; unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/263313 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

2025年中期业绩亮点- 业务总收益同比增长9.40%至约新台币585.31百万元- 毛利同比增长28.98%至约新台币201.97百万元- 整体毛利率则上升5.24个百分点至约34.51%- 本公司拥有人应占期间全面收益总额同比大幅增长118.02%约至新台币68.24百万元- 统包解决方案的收益约新台币113.69百万元- 每股基本盈利同比增长25.84%至约为新台币4.87仙香港，2025年8月21日 - (亚太商讯 via SeaPRwire.com) - 靖洋集团控股有限公司（「  靖洋集团」或「集团」，股份代号：8257.HK）宣布截至 2025年6月 30 日止六个月（「期内」）之中期业绩。期内，集团业绩呈现稳健增长态势。集团总收益达约新台币585.31百万元，同比增长9.40%。毛利同比增长28.98%，达约新台币201.97百万元，而整体毛利率则上升5.24个百分点至约34.51%。本公司拥有人应占期间全面收益总额约新台币68.24百万元，同比大幅增长118.02%。每股基本盈利约为新台币4.87 仙，同比增长25.84%。期内，统包解决方案的收益约新台币113.69百万元，占集团总收益约19.42%。零件及二手半导体制造设备买卖的收益约新台币471.62百万元，零件及买卖二手半导体制造设备占集团总收益约80.58%。本集团秉持着审慎、稳健的核心策略，致力强化与现有国际客户合作的稳定性和持续性，同时积极拓展新客户以分散风险。期内，本集团源自美国业务的收入较去年大幅增加78.54%，占集团总收益约38.68%，而源自台湾业务的收入则较去年增加48.97%，占集团总收益约49.69%。2025 年上半年，全球半导体市场延续增长态势。在AI 等新技术的驱动下，汽车电子、新能源、物联网、大数据和人工智能等领域的新技术、新产品渗透率持续提升。此外，「人工智能+」、「5G+」等前沿技术的深化发展，以及AI 算力需求的快速增长，均成为推动半导体需求的重要动力，为半导体企业营造了良好的发展环境。根据半导体产业协会最新报告，2025年5月全球半导体销售额达590亿美元，较2024年5月的492亿美元增长19.8%，连续19个月实现同比增长；环比则增长3.5%。全球芯片市场的增长主要受美洲和亚太地区强劲需求推动。靖洋集团主席兼行政总裁杨名翔先生总结：「在AI 技术的强劲驱动下，半导体行业迎来经济利润快速增长期。然而，当前国际形势波动，其亦面临供应链稳定性的挑战。本集团将审时度势，稳中求进，持续提升核心价值与竞争力，为股东创造可持续的长期投资回报。」关于靖洋集团控股有限公司（股份代号：8257.HK）靖洋集团控股有限公司为一间总部位于台湾的零件及二手半导体制造设备的统包解决方案供货商及出口商。集团自于2009年开始业务以来，主要为客户提供零件二手半导体制造设备件的统包解决方案，按客户需要改造及/或升级其生产系统的半导体设备，亦从事半导体制造设备及其零件买卖。集团所提供的半导体制造设备及零件包括热炉管、显影装置等，用于半导体的前端制造过程、晶圆加工，如沉积、光阻涂布及显影，更可广泛应用于手机、游戏机、DVD播放器，以及车用传感器等数码电子产品。本新闻稿由汇滔顾问有限公司代表靖洋集团控股有限公司发布。详情垂询：刘育然小姐电话：(852) 2529 7999电邮：Natural.lau@vitalink.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

2025 Interim Results Highlights- Total revenue increased by 9.40% YoY to approximately NTD585.31 million- Gross profit increased by 28.98% YoY to approximately NTD201.97 million- Overall gross profit margin rose by 5.24 percentage points to approximately 34.51%- Total comprehensive income attributable to owners of the Company for the period increased significantly by118.02% YoY to approximately NTD68.24 million- Revenue from turnkey solutions reached approximately NTD113.69 million- Basic earnings per share increased by 25.84% YoY to approximately NTD4.87 centsHONG KONG, Aug 21, 2025 - (ACN Newswire via SeaPRwire.com) - Genes Tech Group Holdings Co. Ltd (“Genes Tech Group” or “The Group”, Stock Code: 8257.HK) announces its interim results for the six months ended 30 June, 2025 (“During the period”). During the period, the Group’s performance demonstrated steady growth. The total revenue of the Group reached approximately NTD585.31 million, representing a year-on- year (“YoY”) increase of 9.40%. Total comprehensive income attributable to owners of the Company for the period amounted to approximately NTD68.24 million, representing a significant YoY increase of 118.02%. Basic earnings per share were approximately NTD4.87 cents, representing a YoY increase of 25.84%.During the period, revenue from turnkey solutions amounted to approximately NTD113.69 million, accounting for approximately 19.42% of the Group’s total revenue. The revenue from trading of parts and used SME amounted to approximately NTD471.62 million, accounting for approximately 80.58% of the Group’s total revenue. The Group adheres to its core strategy of prudence and stability, striving to strengthen the stability and continuity of cooperation with existing international clients while actively expanding new clientele to diversify risks. During the period, the Group’s revenue from operations in the United States increased significantly by 78.54% from last year, accounting for approximately 38.68% of the total revenue of the Group, while revenue from operations in Taiwan increased by 48.97% from last year, accounting for approximately 49.69% of the total revenue the Group.In the first half of 2025, the global semiconductor market continued its growth momentum. Driven by new technologies such as AI, the penetration rates of new technologies and products in areas such as automotive electronics, new energy, the Internet of Things, big data and artificial intelligence continued to rise. Furthermore, the deepening development of cutting-edge technologies such as “AI+” and “5G+”, along with the rapid growth in demand for AI computing power, have become key drivers of semiconductor demand, creating a favorable development environment for semiconductor companies. According to the latest report from the Semiconductor Industry Association (SIA), global semiconductor sales reached USD59 billion in May 2025, up 19.8% from USD49.2 billion in May 2024, marking 19 consecutive months of year-on-year growth and a 3.5% increase from the previous month. The growth in the global chip market was primarily driven by strong demand from the Americas and Asia- Pacific regions.Mr. Yang Ming-Hsiang, Chairman and Chief Executive Officer concluded: “Driven by the strong momentum of AI technology, the semiconductor industry is entering a period of rapid growth in economic profits. However, amidst the current volatile international landscape, the semiconductor industry faces challenges in supply chain stability. The Group will assess the situation, pursue progress while maintaining stability, and continuously enhance its core value and competitiveness to create sustainable long-term investment returns for shareholders.”About Genes Tech Group Holdings Co. Ltd (Stock Code: 8257.HK)Genes Tech Group Holdings Co. Ltd is a turnkey solution provider and exporter of parts and used SME in Taiwan. Since the commencement of its business in 2009, the Group mainly engaged in providing turnkey solution for parts and used SME for its customers and modifying and/or upgrading the semiconductor equipment of its production systems according to customers needs. In addition, the Group is also engaged in the trading of SEM and parts. The SME and parts supplied by the Group included furnaces, clean tracks and other related items, which were used at the front-end of the semiconductor manufacturing process, wafer fabrication such as deposition, photoresist coating and development, and these were extensively applied in mobile phones, game consoles, DVD players, automotive sensors and other digital electronic products.The press release is distributed by Vitalink Consultants Limited on behalf of Genes Tech Group Holdings Co. Ltd. For enquiry, please contact:Ms. Natural Lau  Tel: (852) 2529 7999  Email: Natural.lau@vitalink.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年8月21日 - (亚太商讯 via SeaPRwire.com) - 大洋集团控股有限公司 (「大洋集团」或「集团」；股份代号：1991) 作为在港上市近廿载的老牌港股，拟进一步向Web4.0领域及人工智能（AI）产业全面进军，将以AI数字人作为其后续成长引擎，结合真实世界资产（Real World Assets，RWA）代币化运营平台，及其固有的全球流量营销运营体系，针对教育、游戏、大健康三大万亿赛道进行战略布局。在人工智能（AI）为全球数字化卷起新浪潮的大局下，AI正从「技术工具」跃升成为不少企业的「变革核心」，并驱使各行业改变工作方式、突破效率边界、重塑其价值逻辑。IDC研究显示，企业每投资1元在生成式AI身上，其投资回报率可达3.7倍；而深度拥抱AI的企业已实现平均13个月的价值回报周期，超过50%的组织正加速定制化AI应用开发，将短期收益转化为长期竞争优势。普华永道预测，到2030年，AI将成为全球经济的规则改变者，贡献高达 15.7 万亿美元的增长，为中国经济带来约26.1%的 GDP增量。无怪AI数字人作为不同行业多模式交互核心载体，已逐步从概念迈向产业落地。大洋集团于2023年投资的专业数位营销服务公司巨省科技有限公司（「巨省科技」）拟推出其自主研发、技术融合机器学习、自然语言处理（NLP）、计算机视觉（CV）、语音合成／识别（TTS／STT）等领先技术、可兼容xAI Grok API的AI数字人，此AI数字人处于行业领先水平，幷拟面向教育、游戏及大健康的三大场景推出，形成包括但不限于，如能够根据学生专注力实时调整语速及学习难度的「虚拟老师」AI数字人、藉因应每位玩家不同选择互动而衍生「玩家专属」的剧情之AI NPC、可根据个人7x24小时的健康数据如心率、血压等主动建议的「健康伴侣」AI数字人等；集团计划采取「分阶段迭代、逐步开放」的策略，即预期将于未来6个月内完成核心模块及底层技术整合，并目标于紧接的第6至18个月就上述三大场景发布AI数字人原型，幷接入巨省科技之营销矩阵，期望于第18至36个月内能开放相关API或SDK接口，并吸引全球开发者构建其开放式生态圈。除此之外，集团更拟透过是次向AI与数字化转型的契机，计划透过区块链RWA（Real World Assets，真实世界资产），将具备现金流的链下资产项目通过AI数字人实时抓取写进智能合约当中，并将针对教育版权、游戏IP在内等资产进行分层打包及发行，以配合不同投资者的风险偏好，集团目标此类资产发行，首年将对10个优质项目进行「试水式」发行，冀能于未来3年扩展至100个项目，涉及资产规模总值5亿港元；力争5年内服务的资产规模总值能突破50亿港元，打造出多领域RWA资产运营平台。值得留意的是，RWA交易过程中，无需传统经纪商或中间机构的参与，便可实现实体经济与虚拟市场的结合。根据波士顿咨询顾问公司的估计 =，至2030年，RWA代币化市场的市值规模可能成长至16万亿美元。由此可见，其巨大的市场潜力以至前景。依托巨省科技20年跨境投放经验，大洋集团将构建「全域覆盖+智能运营+规模增长」流量体系。巨省科技服务之平台覆盖TikTok、Instagram、Facebook等海外社交平台及抖音、微信视频号等国内渠道，有助客户实现全球用户触达；并可借助AI技术实现账号养号、内容生成、定向投放全流程自动化，降低运营成本，提升获客效率。以此推算，大洋集团对用户增长目标明确：首年引流100万用户构建初始流量池，目标3年内超千万，5年内打造亿级Web4.0原生流量池，形成「流量－转化－复购」的循环。大洋集团将藉上述规划打造「数据化（Digitalization）－资产化（Assetization）－代币化（Tokenization）（下称‧DAT）」闭环，实现价值三层转化：于数据化阶段，将教育教案、游戏脚本等多元数据标准化，打破数据孤岛；在资产化阶段，将用户交互沉淀换算为可量化资产，比如教育「个性化教研数据包」可提升AI数字人老师课程之续费率、游戏「剧情扩展资产」延长游戏生命周期等；在代币化阶段，将可通过滴灌通DRO模型质检之达标资产上链发行，全球投资者可7×24小时交易，放大流动性溢价。针对上述AI及数字化转型战略蓝图的投入规划，大洋集团预期首年投入1.3亿港元，目标未来5年内实现现金流正向循环。大洋集团主席施琦女士表示：「大洋发布助力企业AI与数字化转型蓝图，并正式进入数字资产领域，标志着集团一项重要里程碑，亦为未来更多元化发展掀开崭新的一页。我们感谢各投资者对公司以发展的肯定及信心。大洋集团作为一间在港上市近廿载的老牌港股，透过是次涉足AI产业的举措，未来有望衍生四种收入，包括AI数字人引流的收入、为中小企业提供 AI+RWA 一站式融资咨询的收入、与RWA交易相关的撮合手续费以至数字投顾订阅费、以及按项目或年费提供多语言、多文化 AI 客服与营销外包收入，且巨省科技受惠其业态，近年持续保持正向现金流，亦为是次其向AI及数字转型进一步拓展大计，提供充裕的自有资源，而随着集团透过巨省科技走入AI领域的蓝图逐步变成现实，届时可望为股东创造更多价值幷带来理想回报。」关于大洋集团控股有限公司(股份代号: 1991)大洋集团控股有限公司（股票代号：1991）成立于 1991 年，2007 年在香港联合交易所有限公司成功上市，是一家兼具三十年产业积淀与前瞻数字视野的多元化企业。自创立以来，集团早期聚焦硅胶输入设备领域，专业设计及制造用于消费电子装置、计算机、笔记本电脑、手提电话及汽车周边产品的核心部件，凭借高度整合的生产体系、严苛的品质管控与技术创新能力，赢得全球众多知名品牌客户的长期信赖，奠定了坚实的产业根基。随着全球数字化转型浪潮的深化，大洋集团敏锐洞察数字经济时代的战略机遇，果断启动向 Web4.0 领域的全方位战略转型，以「拥抱技术变革、重构价值生态」为核心方向，精准锚定人工智能（AI）、真实世界资产（RWA）代币化及香港政策生态三大核心驱动力，致力于打通 「数据 — 资产 — 价值」 的转化链路，开启从传统制造向数字经济领航者的跨越。当前，大洋集团正以 Web4.0 战略转型为新起点，聚焦教育、游戏、大健康三大万亿赛道，致力于成为亚太地区 AI 与 RWA 双赛道的领先企业，为全球投资者、合作伙伴及个人用户提供高效的价值增长生态，持续推动全球数字经济高质量发展，写下从「产业深耕者」到「数字生态构建者」的全新一页。如有任何问题，欢迎垂询达博思传讯顾问有限公司陈铠瑶(Joanne Chan)电话：(852) 9616 2676 电邮：jchan@lbs-comm.com何幸儒 (Jason Ho) 电话：(852) 9836 3448 电邮：jho@lbs-comm.com Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 21, 2025 - (ACN Newswire via SeaPRwire.com) - Ta Yang Group Holdings Limited (“Ta Yang Group” or the “Group”; Stock Code: 1991), a well-established Hong Kong-listed company with nearly two decades of market presence, plans to further advance comprehensively into the Web 4.0 field and artificial intelligence (AI) industry. The Group will leverage AI Digital Humans as its subsequent growth engine, integrating a Real World Assets (RWA) tokenization operation platform with its inherent global traffic marketing operation system to strategically deploy across three trillion-dollar sectors: education, gaming, and big health.Against the backdrop of AI fueling a new wave of global digitization, AI is evolving from a “technological tool” to the “core of transformation” for many enterprises, driving industries to change work methods, overcome efficiency boundaries, and reshape value paradigms. IDC research indicates that for every dollar invested in generative AI, enterprises can achieve a return on investment of 3.7 times; companies deeply embracing AI have realized an average value return cycle of 13 months. Over 50% of organizations are accelerating customized AI application development, converting short-term gains into long-term competitive advantages. PwC forecasts that by 2030, AI will be a global economic game-changer, contributing up to US$15.7 trillion in growth and adding approximately 26.1% to China’s GDP. It is no surprise that AI Digital Humans, as the core multi-modal interactive carriers across industries, are gradually transitioning from concept to industrial implementation.In 2023, the Group invested in Jusheng Technology Co., Ltd. (“Jusheng Technology”), a professional digital marketing services company. Jusheng Technology plans to launch its independently developed AI Digital Humans, integrating leading technologies such as machine learning, natural language processing (NLP), computer vision (CV), speech synthesis/recognition (TTS/STT), and compatible with the xAI Grok API. This AI Digital Human is at an industry-leading level and will be introduced to three major scenarios: education, gaming, and big health. This includes, but is not limited to: a “Virtual Teacher” AI Digital Human that can adjust speaking speed and learning difficulty in real time based on students’ attention; AI NPCs in games with personalized storylines that evolve based on different player choices; and a “Health Companion” AI Digital Human offering proactive suggestions based on individuals’ 24/7 health data such as heart rate and blood pressure. The Group plans a “phased iterative and gradual open” strategy, expecting to complete the core modules and underlying technology integration within six months, release AI Digital Human prototypes for the three scenarios in the following 6 to 18 months, and integrate these into Jusheng Technology’s marketing matrix. Between 18 and 36 months, the Group aims to open related APIs or SDKs and attract global developers to build an open ecosystem.Additionally, the Group intends to take advantage of this AI and digital transformation opportunity by using blockchain-based RWA to enable off-chain cash flow-generating asset projects to be captured in real time by AI Digital Humans and recorded in smart contracts. The Group will structure and issue layered packages of assets including educational copyrights and gaming IPs tailored to investors’ risk preferences. The target for this type of asset issuance is to pilot 10 high-quality projects in the first year, with plans to expand to 100 projects within three years, involving total asset values of HK$500 million. The Group aims to serve total asset values exceeding HK$5 billion within five years, establishing a multi-domain RWA asset operation platform.It is noteworthy that RWA transactions eliminate the need for traditional brokers or intermediaries, enabling a direct connection between the physical economy and virtual markets. According to Boston Consulting Group estimates, the RWA tokenization market could grow to a valuation of US$16 trillion by 2030, underscoring its vast market potential and promising outlook.Leveraging Jusheng Technology’s 20 years of cross-border marketing experience, Ta Yang will build a traffic system characterized by “comprehensive coverage + intelligent operation + scalable growth.” Jusheng Technology’s platforms cover overseas social media such as TikTok, Instagram, Facebook, as well as domestic channels like Douyin and WeChat Video Accounts, facilitating global user reach for customers. Utilizing AI technology, processes such as account nurturing, content generation, and targeted delivery will be fully automated to reduce operational costs and improve customer acquisition efficiency. Based on this, Ta Yang Group has a clear user growth target: to attract 1 million users in the first year to form an initial traffic pool, reach over 10 million users within three years, and build a native Web 4.0 traffic pool of hundreds of millions of users within five years, creating a “traffic – conversion – repurchase” cycle.Ms. Shi Qi, Chairlady of Ta Yang Group, stated, “Ta Yang is unveiling its AI transformation blueprint and formally entering the digital asset arena, marking a significant milestone for the Group and opening a new chapter for future development. We are grateful for investors’ recognition and confidence in our growth. As a well-established Hong Kong-listed company with nearly two decades of market history, this entry into the AI industry is expected to generate four types of revenue: income from AI Digital Human-driven traffic; revenue from providing AI+RWA one-stop financing consultancy services to SMEs; matchmaking fees related to RWA transactions, as well as digital advisory subscription fees; and multilingual, multicultural AI customer service and marketing outsourcing fees charged on a per-project or annual basis. Benefiting from its business model, Jusheng Technology has maintained positive cash flow in recent years, providing ample resources for this broader AI and digital transformation initiative. As the Group’s vision through Jusheng Technology in AI gradually materializes, we look forward to creating greater value and delivering promising returns for our shareholders.”About Ta Yang Group Holdings Limited (SEHK: 1991.HK)Ta Yang Group Holdings Limited (Stock Code: 1991) was established in 1991 and successfully listed on The Stock Exchange of Hong Kong Limited in 2007. It is a diversified enterprise combining three decades of industry experience with a forward-looking digital vision. Since its founding, the Group initially focused on the field of silicone input devices, specializing in the design and manufacture of core components used in consumer electronic devices, computers, laptops, mobile phones, and automotive peripherals. Leveraging a highly integrated production system, stringent quality control, and technological innovation capabilities, the Group has earned long-term trust from numerous globally renowned brand clients, laying a solid industrial foundation.With the deepening wave of global digital transformation, Ta Yang Group has keenly identified strategic opportunities in the digital economy era and decisively launched a comprehensive strategic transformation toward the Web 4.0 domain. Centered on “embracing technological change and reshaping the value ecosystem,” the Group precisely anchors on three core drivers: artificial intelligence (AI), Real World Assets (RWA) tokenization, and Hong Kong’s policy ecosystem. It is dedicated to bridging the transformation chain of “data — assets — value,” marking its leap from a traditional manufacturing enterprise to a digital economy pioneer.Currently, Ta Yang Group regards its Web 4.0 strategic transformation as a new starting point, focusing on the three trillion-dollar sectors of education, gaming, and big health. It aims to become a leading enterprise in the Asia-Pacific region across the dual arenas of AI and RWA, providing efficient value growth ecosystems for global investors, partners, and individual users. The Group is committed to continuously advancing high-quality development of the global digital economy and writing a new chapter from being an “industry deep cultivator” to a “digital ecosystem builder.” Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 21, 2025 - (ACN Newswire via SeaPRwire.com) - Focusing on the field of tumor treatment, innovative biopharmaceutical company Lepu Biopharma Co., Ltd. (Lepu Biopharma or the Company, stock code: 2157.HK) announced its interim results for the first half of 2025. During the reporting period, the Company's business showed strong growth momentum, achieving profitability for the first time. Core product sales and international licensing business progressed in tandem, with multiple ADC pipeline products entering key clinical stages and global commercialization efforts accelerating.Lepu Biopharma is an innovation-driven biopharmaceutical company focusing on oncology therapeutics, in particular, targeted therapy and oncology immunotherapy, with a strong China foundation and global vision. Lepu Biopharma is dedicated to developing innovative ADCs through our comprehensive and advanced ADC technology development platform and we aim to develop optimal and innovative drugs to better serve the unmet medical needs of cancer patients. The Company is committed to continuously developing a market-differentiating pipeline by fully integrating independent innovation capabilities and strategic collaborations. The Company has established and is progressively expanding our internal manufacturing capabilities, driven by the business needs stemming from the upcoming commercialization of our ADC candidates.Currently, Lepu Biopharma has strategically designed our pipeline with a range of oncology products. For clinical-stage candidates, the Company has one clinical/commercialization-stage drug candidate; nine clinical-stage drug candidates, including one co-developed through a joint venture; and three clinical-stage combination therapies of our candidates. One of our drug candidates has obtained marketing approval with respect to two of its targeted indications, with clinical trials for other indications ongoing. Among the nine clinical-stage drug candidates, seven are targeted therapeutics and two are immunotherapeutics, which are an oncolytic virus drug and T cell agonistic antibody.As of the end of the reporting period, Lepu Biopharma has achieved significant milestones in the monetisation of our R&D capabilities through commercialization and BD activities: PUYOUHENG (Pucotenlimab Injection) has completed the full commercialization process and is currently under a rapid sales growth, and four other products, CMG901, MRG007 and two pre-clinical TCE assets have also been licensed out through our BD activities. Notably, CMG901’s global rights have been licensed to AstraZeneca, and MRG007’s rights for regions outside Greater China have been licensed to ArriVent. Two pre-clinical TCE assets have entered into a collaboration with Excalipoint.Revenue scale achieved a 3.5-fold leapfrog growth, with comprehensive improvement in financial indicatorsIn the first half of 2025, the Company made significant progress in advancing its product pipeline and business operations, recording a total revenue of approximately RMB466 million, which was an increase of 350% of the same period in 2024 at RMB133 million. For licensing activities, the Company has recognized approximately RMB309 million in revenue primarily from the out-licensing of MRG007. The Company recorded a revenue of approximately RMB151 million for the sales of PUYOUHENG (Pucotenlimab Injection), marking a significant increase of 58.8% from the sales recorded in the same period in 2024. In addition, the Group recognized approximately RMB6.3 million in revenue for the provision of CDMO services.During the reporting period, the Company achieved profitability for the first time, with a profit of approximately RMB 29.3 million, marking a turnaround from a loss in the same period of 2024. Net cash generated from operating activities was approximately RMB 46.7 million, and cash and cash equivalents increased to approximately RMB 473 million, representing a positive net operating cash flow compared to the same period in 2024. Research and development expenses amounted to approximately RMB 202 million, representing a decrease of 6.6% compared to the same period in 2024. While ensuring the advancement of core pipelines, cost control measures have shown tangible results.The Company actively develops cooperative relationships with various business channel partners. As of June 30, 2025, the Company completed the tendering process on the procurement platform in 28 provinces of the PRC. We have covered approximately 118 cities in the PRC through various sales channels, and we will further expand our sales network.ADC pipeline enters the critical phase with multiple products, potential for combination therapy highlighted, and fruitful international licensing resultsIn the first half of 2025, the Company remained focused on the research and development of its drug candidates, while continuously assessing market demand and competitive landscape relating to the range of oncology therapeutics and the broad spectrum of indications covered by its drug candidates, in order to maximize the competitiveness of its products pipeline. In particular, MRG003 for NPC nears approval and other key drug candidates advance to pivotal clinical stage.MRG003（EGFR-ADCNPC: MRG003 is under NDA review for the treatment of R/M NPC and has also been granted priority review by the CDE of NMPA. The authority is currently proceeding with the clinical and pharmaceutical evaluation of MRG003. The encouraging data of the pivotal Phase IIb clinical study for the treatment of R/M NPC was read out as “late breaking abstract (LBA)” for oral presentation at the ASCO Congress 2025. The Company is also currently conducting the Phase III clinical trial of combination therapy with MRG003 and pucotenlimab on R/M NPC. The encouraging data in phase II clinical trial of combination therapy on R/M NPC will be presented at the ESMO Congress 2025.HNSCC: As of June 30, 2025, the Company is conducting a randomized, open-label, multicenter Phase III clinical study on HNSCC. In terms of combination therapy with MRG003 and pucotenlimab, we are currently conducting the Phase II clinical trial on HNSCC, and the encouraging data in phase II clinical trial will be presented at the ESMO Congress 2025. The  European Medicines Agency (EMA) granted Clinical Trial Authorization (CTA) approvals for the Phase II clinical trial targeting LA-SCCHN in June 2025, and the Company will initiate the clinical trial in the second half of 2025.MRG004A (TF-ADC): The Company has completed the Phase I clinical study on solid tumors in China and the encouraging Phase Ib expansion data on PC will be presented at the ESMO Congress 2025. Protocol communication with CDE for the pivotal clinical trial of MRG004A has been completed, and we have entered the Phase III clinical trial stage in August 2025. In addition, MRG004A was granted BTD by the CDE in August 2025, which offers a brand-new treatment option to patients with pancreatic cancer.MRG006A (GPC3-ADC): MRG006A is a GPC3-targeted ADC with FIC potential globally. We received IND clearance from the FDA in January 2025. We are currently advancing Phase I clinical trial in China. In pre-clinical studies, MRG006A resulted in a robust and dose-dependent tumor growth inhibition on multiple CDX models and HCC PDX models. In the meantime, MRG006A also demonstrated good tolerability in the exploratory toxicology study.MRG007 (CDH17-ADC): We received the IND approval from the NMPA in June 2025 and are currently conducting a Phase Ia clinical trial for the treatment of unresectable locally advanced or metastatic solid tumors. MRG007 has shown robust antitumor activity in preclinical models of GI cancers and a favorable therapeutic index based on IND enabling studies. The pre-clinical data of MRG007 was presented at the AACR Annual Meeting in April 2025. In January 2025, the Company entered into an exclusive licensing agreement with ArriVent, pursuant to which the Company has granted ArriVent exclusive rights to develop, manufacture and commercialize MRG007 outside of Greater China. Under the terms of the agreement, the Company is eligible to receive up to US$1.2 billion in total in upfront payment and development, regulatory and sales milestones, together with tiered royalties on net sales. As of June 30, 2025, the upfront payment has been received.CG0070 (Oncolytic virus): CG0070 was granted BTD by the CDE in January 2025. CG0070 is currently in a MRCT Phase III clinical study conducted by the Company’s U.S. partner, CG Oncology. The latest encouraging data observed has been orally presented in the 120th American Urological Association Annual Meeting in April 2025. The Company has completed the Phase I clinical trial in China and are currently engaged in protocol communication with the CDE regarding the domestic bridging pivotal linical trial.Combination therapy layout: As of June 30, 2025, the Company has completed the Phase II trial of combination therapy with MRG002 and pucotenlimab in the treatment of HER2-expressing solid tumors, which has moved to first-line treatment, and protocol communication for phase III clinical trial has been completed. The Company has observed encouraging data on UC. In terms of combination therapy with MRG003 and pucotenlimab, the Company is currently conducting the Phase II clinical trial on HNSCC, which has moved to first-line treatment, and the encouraging data in phase II clinical trial will be presented at the ESMO Congress 2025. The European Medicines Agency (EMA) granted Clinical Trial Authorization (CTA) approvals for the Phase II clinical trial targeting LA-SCCHN in June 2025, and we will initiate the clinical trial in the second half of 2025, which has been moved up to first-line treatment for advanced disease.Preclinical: Laying the groundwork for innovative platforms and innovative targetsThe Company continuously strives to build up and develop novel technology platforms as innovative engines for the Company. The Company has developed multiple innovative linker-payload platforms for ADC drug candidates, including the Hi-TOPi ADC platform and other early-stage platforms. During the reporting period, our innovative ADC platforms have achieved significant progress. Based on these innovation platforms, the Company has generated two ADC candidates, which are MRG006A with global first-in-class potential and MRG007 with global best-in-class potential, all of which have shown encouraging pre-clinical data and received IND approvals in China. Pre-clinical data of MRG007 was presented at the AACR Annual Meeting in April 2025.On August 1, 2025, the Company entered into a licensing transaction for the license-out and/or transfer of certain intellectual property rights relating to two preclinical assets developed by the Company’s proprietary T cell engager-TOPAbody platform with Excalipoint through entering into the Intellectual Property Assignment and License Agreement.The Company shall receive (i) an upfront payment in cash of US$10 million in aggregate, development and commercial milestone payments in cash of up to US$847.5 million in aggregate and sales royalties, holding a 10% interest, marking international recognition of the platform's value.Future Outlook: Accelerating the Commercialization of Core Products and Advancing Global Strategic DevelopmentIn respect of drug R&D, the Company will further focus on advancing strategic research and development priorities in next generation ADC drugs and IO bi/tri specific antibodies, while accelerating the commercialization of late-stage products. For our registrational stage product MRG003, the relevant authority is currently proceeding with the clinical and pharmaceutical evaluation in an orderly manner. The Company will concentrate our resources and endeavour to expedite the approval process. Meanwhile, our other key drug candidates are entering pivotal clinical stages. Protocol communication for the pivotal clinical trial of MRG004A has been completed, and we have entered the Phase III clinical trial stage in August 2025. In addition, we are currently conducting protocol communication with the CDE regarding the domestic pivotal clinical trial of CG0070. The Company will also explore further potential clinical value of our other innovative drug candidates, such as MRG006A and MRG007. Concurrently, the potential efficacy of combination therapies within our pipeline is being continuously explored, with greater clinical benefits striving to be delivered to a broader patient population.In terms of domestic commercialization, the Company will take further actions to enhance the market accessibility of PUYOUHENG (Pucotenlimab Injection), accelerating market penetration at all levels to further increase market share and enhance the Company's brand image and market recognition. At the same time, the Company will commence the preparation process for the commercial launch of MRG003 and continue to expand our marketing and commercialization teams.On the international front, the Company will ramp up our efforts to expand into the global market. We will expand our international network and explore new business development cooperation opportunities. The Company will remain committed to seeking more strategic partners worldwide to develop our ADC products and other innovative candidates through partnerships, licensing agreements, or joint ventures. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHENZHEN, Aug 20, 2025 - (ACN Newswire via SeaPRwire.com) - Following its highly anticipated global reveal earlier this month, Level Infinite will launch the game's 1st Closed Beta in early November. Players can be the first to get a hands-on with the game this week at gamescom 2025 in Cologne from 20th to 24th August. Rust Mobile delivers a full-scale open-world survival gameplay that millions of fans know and love, optimized for mobile devices.Officially licensed by Facepunch Studios, Rust Mobile stays true to the spirit of the original while introducing a fresh way to survive on the go. From gathering resources and building fortified bases to ruthless PvP combat and the tension of trust and betrayal, the mobile version captures the essence of Rust. Players will have the opportunity to experience all the excitement the game offers firsthand at both gamescom and through the upcoming Closed Beta Test.Rust Mobile at Gamescom 2025Attendees can find the Rust Mobile booth in Hall 06.1 - C-051G, where they'll get hands-on time with the game and take part in activities designed to bring the world of Rust to life. Activities include interacting with themed props, immersing themselves in the booth environment.Every participant will also earn a spin on the Loot Wheel, with the chance to win exclusive Gamescom 2025 memorabilia, including limited-edition posters and tote bags.1st Closed Beta Coming This NovemberRust Mobile's 1st Closed Beta will launch in early November 2025, inviting 30,000 players from North America, Western Europe, and select regions in Asia.The beta will feature four language options English, Japanese, Traditional Chinese, and Thai and will support iOS, Android, and tablet devices, ensuring players can experience the game on their platform of choice.Registration for the Closed Beta Test is now open at www.rustmobile.comFor more information about Rust Mobile or to pre-register, head to rustmobile.com, or follow the game on X, and YouTube. For gamescom opening times visit www.gamescom.global.About Level InfiniteLevel Infinite is Tencent's global games brand, dedicated to delivering engaging and original gaming experiences to a worldwide audience, whenever and wherever they choose to play. The brand also provides a wide range of services and resources to a network of developers and partner studios around the world to help them unlock the potential of their games. Level Infinite is both publisher of breakout hit games like PUBG MOBILE, Honor of Kings and Goddess of Victory: NIKKE and a collaborative partner in games such as Dune: Awakening from Funcom, Warhammer 40K: Darktide and many more. To learn more about Level Infinite, visit www.levelinfinite.comContact InformationKirsty EndfieldSwipe Right PRtencent@swiperight.ggSOURCE: Level Infinite Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年8月21日 - (亚太商讯 via SeaPRwire.com) - 比优集团控股有限公司（「比优集团」或「本公司」，连同其附属公司统称「本集团」，股份代号：09893.HK）欣然宣布，近日集团获国内领先金融数据平台Wind提升ESG评级，由BB级跃升至A级，跻身行业前列，充分体现集团在可持续发展方面的卓越表现。Wind ESG评级A级代表企业在环境、社会及管治维度的综合实力处于行业头部领先水平。据Wind最新评级结果显示，在基础化工行业中，获得A级的企业仅占约19.35%，显示出比优集团在ESG管理及实践方面已居于行业上游。本集团ESG评级实现从BB至A的两级跨越，主要得益于系统性的可持续发展举措。根据比优集团最新发布的《2024/2025年度环境、社会及管治报告》，集团在环境层面全面落实大气污染物减排、温室气体管控、废弃物资源化及生态修复等项目，大力推进绿色矿山建设与社会责任履行；在社会维度，持续完善安全生产体系与员工健康保障，强化产品质量与供应链合规管理，特别是在"一带一路"沿线国家推行本地化运营，积极践行社区共建与企业公民责任；在管治维度，集团建立了系统、全面的合规管理制度和风险控制流程，通过常态化的审计监察与员工培训，严守商业道德底线，积极预防舞弊与腐败行为，并设立了对董事会直接负责的ESG工作组，将可持续发展深度融入公司治理核心。Wind作为中国金融信息服务业最具权威性与影响力的平台之一，其ESG评级体系依托强大的数据治理能力与深厚的行业积累，构建了涵盖大量定量与定性指标的科学评估框架。该体系接轨国际标准，深度融合中国本土信息披露政策与企业实践，Wind ESG评级结果与底层数据已全面覆盖A股、港股上市公司，公募信用债发债主体及国内公募基金。本次比优集团ESG评级的上调，反映了其在治理结构优化、环境与社会绩效提升、以及信息披露质量方面获得第三方评级机构的高度认可。董事会相信，此次评级的跃升不仅体现了集团在可持续发展方面的扎实进展，也将进一步强化投资者的信心。未来，比优集团将继续深化绿色运营、推进技术革新，持续提升ESG管理的透明度，积极践行可持续发展理念，推动实现高质量的企业成长。关于比优集团控股有限公司比优集团控股有限公司（主板股票代号：09893.HK）是一家专注于民用爆炸品的生产销售、爆破工程服务，矿山资源开发和勘探业务的领军企业。集团在国内市场占据重要份额，并在中亚等全球市场积极拓展业务。公司网址：http://www.pizugroup.com Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

深圳, 2025年8月20日 - (亚太商讯 via SeaPRwire.com) - 在本月早些时候备受期待的全球首秀之后，Level Infinite 将于11月初开启《Rust Mobile》首次封闭测试。玩家们可以在 2025 年 8 月 20 日至 24 日于科隆举办的 gamescom 上，率先亲身体验这款游戏。《Rust Mobile》将经典的开放世界生存玩法完整呈现，并针对移动设备进行了优化，让数百万粉丝熟悉并热爱的体验随时随地都能上手。本作由 Facepunch Studios 官方授权，在忠实还原原作精神的同时，也为移动端带来全新的生存方式。从收集资源、建造坚固基地，到残酷的 PvP 战斗，以及伴随信任与背叛而来的紧张氛围，移动版完整呈现了《Rust》的核心精髓。玩家不仅能够在 gamescom 上率先感受游戏的魅力，还可通过即将到来的封闭测试进一步体验其独特乐趣。《Rust Mobile》亮相 2025 科隆游戏展参展观众可前往 06.1 展馆 - C-051G 展位，在这里亲身体验游戏，并参与一系列将《Rust》世界带入现实的特色活动。活动包括与主题道具互动、沉浸式感受展位环境等。每位参与者都将获得一次转动“战利品转盘”的机会，有机会赢取 2025 科隆游戏展独家纪念品，包括限量版海报和环保袋。首次封闭测试将于今年11月开启《Rust Mobile》首次封闭测试将于 2025 年 11 月初上线，届时将邀请来自北美、西欧及部分亚洲地区的 30,000 名玩家参与。本次测试将提供四种语言版本：英语、日语、繁体中文和泰语，并支持 iOS、Android 及平板设备，确保玩家能够在自己熟悉的平台上畅玩游戏。封闭测试现已开放注册，玩家可前往 www.rustmobile.com 报名。欲了解更多有关《Rust Mobile》的信息或进行预注册，请访问 rustmobile.com，或关注游戏的 X 账号与  YouTube 频道。有关科隆游戏展开馆时间，请访问 www.gamescom.global。关于 Level InfiniteLevel Infinite 是腾讯旗下的全球游戏品牌，致力于随时随地为全球玩家带来引人入胜且独具特色的游戏体验。该品牌还为全球范围内的开发者和合作工作室提供多种服务与资源，帮助他们释放游戏潜力。Level Infinite 既是《PUBG MOBILE》《王者荣耀》《胜利女神：NIKKE》等爆款游戏的发行商，也是《沙丘：觉醒》（Funcom 开发）、《战锤40K：Darktide》等众多游戏的深度合作伙伴。欲了解更多关于 Level Infinite 的信息，请访问 www.levelinfinite.com 。联系信息Kirsty EndfieldSwipe Right PRtencent@swiperight.gg来源: Level Infinite Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - August 20, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc. ("Red Cloud"), as sole underwriter and bookrunner, pursuant to which Red Cloud has agreed to purchase for resale 5,555,556 units of the Company (each, a "Unit") at a price of C$0.90 per Unit (the "Offering Price") on a "bought deal" basis in a public offering for gross proceeds of approximately C$5,000,000 (the "Underwritten Offering").Each Unit will consist of one common share of the Company (each, a "Unit Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant shall entitle the holder to purchase one common share of the Company (each, a "Warrant Share") at a price of C$1.35 at any time on or before that date which is 36 months after the Closing Date (as herein defined).The Company has granted to the Underwriter an option (the "Over-Allotment Option", and together with the Underwritten Offering, the "Offering"), exercisable, in whole or in part, at any time for a period of up to 30 days after and including the Closing Date, to purchase for resale the number of additional Units equal to up to 15% of the number of Units sold pursuant to the Underwritten Offering at the Offering Price to cover over allotments, if any, and for market stabilization purposes.The net proceeds from the Offering will be used by the Company to fund ongoing operations including, but not limited to, commercial development, product development and working capital.In connection with the Offering, the Company intends to file a prospectus supplement (the "Supplement") to the Company's final short form base shelf prospectus dated March 7, 2025 (the "Shelf Prospectus"), with the securities regulatory authorities in each of the provinces and territories of Canada, except Quebec. The Units may also be sold in the United States on a private placement basis pursuant to one or more exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and in such other jurisdictions outside of Canada and the United States, in each case in accordance with all applicable laws provided that no prospectus, registration statement or similar document is required to be filed in such jurisdiction, and provided the issuance of the Units (including the underlying securities) is permitted under laws applicable to the Company (including the Australian Corporations Act 2001 (Cth).Copies of the Shelf Prospectus and the Supplement to be filed in connection with the Offering can be found on SEDAR+ at www.sedarplus.ca. The Shelf Prospectus contains, and the Supplement will contain, important detailed information about the Company and the Offering. Prospective investors should read the Supplement, the Shelf Prospectus and the other documents the Company has filed on SEDAR+ at www.sedarplus.ca before making an investment decision.The Offering is expected to close on or about September 3rd, 2025 (the "Closing Date"), or on such date as agreed upon between the Company and Red Cloud. The closing of the Offering is subject to the Company receiving all necessary regulatory approvals, including the approval of the TSX Venture Exchange to list, on the Closing Date, the common shares of the Company issuable from the sale of Units as well as upon the exercise of the Warrants.This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.About GMGGMG is an Australian-based clean-technology company, which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in-house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low-cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy saving coating), which is now being marketed into other applications, including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium ion batteries.GMG's 4 critical business objectives are:Produce Graphene and Improve/Scale Cell Production ProcessesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the expected size and terms of the Offering, the anticipated timing of closing the Offering, the ability of the Company to satisfy all conditions to closing the Offering, and the expected use of proceeds from the Offering.Such forward-looking statements are based on a number of assumptions of management, including, without limitation, expectations and assumptions concerning the business objectives of the Company; the Company's ability to carry out current planned capital projects, research and development, manufacturing, production, sales and marketing programs for its graphene and graphene-enhanced products and solutions; that the Company will receive the necessary regulatory approvals for the Offering; use the proceeds from the Offering as anticipated; the Company's performance and general business and economic conditions.Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: the risk that the Company is not able to use the proceeds from the Offering as anticipated by management; the risk that the Company does not receive the requisite regulatory approvals for the Offering; overall economic conditions; technical de-risking and market acceptance for the Company's products and solutions; the introduction of competing technologies or products; stock market volatility; environmental and regulatory requirements; competitive pressures; change in market conditions and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied in these forward looking statements; the volatility of global capital markets; political instability; the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel; unexpected development and production challenges; unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/263207 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 20, 2025 - (ACN Newswire via SeaPRwire.com) - To promote Hong Kong’s business advantages and enhance trade and economic cooperation between Hong Kong and Thailand and the wider ASEAN region, Prof Frederick Ma, Chairman of the Hong Kong Trade Development Council (HKTDC), visited Bangkok and met with senior government and business leaders.Prof Ma spoke on a panel at the Singapore Regional Business Forum organised by the Singapore Business Federation. He said, “Businesses are diversifying amid the changing landscape. Asia remains a major engine for economic growth, underpinned by the rise of emerging markets, like ASEAN and the Middle East. China, with its industrial base and vast population, is a stabilising force in an ever-changing world. And Hong Kong, given its superconnector and super value-adder roles, is a dynamic platform linking Mainland China with the world.”Aside from the event, Prof Ma met with Chantawit Tantasith, Deputy Minister of Commerce of Thailand, and Dhanin Chearavanont, Senior Chairman of Charoen Pokphand Group, to exchange views on deepening Hong Kong-Thailand trade and economic cooperation.Prof Ma noted: “Thailand is an important trade and investment partner for Hong Kong. I am delighted that I had the opportunity to exchange insights with the Ministry of Commerce and leading enterprises in Thailand as well as political and business leaders from Singapore to further strengthen the economic ties between Hong Kong and Thailand and the wider ASEAN region.”As a statutory body, the HKTDC promotes, assists and develops Hong Kong’s external trade, while supporting Hong Kong businesses to tap into the opportunities in ASEAN. The HKTDC’s flagship events, such as the Asian Financial Forum and the Belt and Road Summit, serve as ideal platforms to highlight the latest developments and opportunities in Hong Kong as well as the city’s advantages in professional services, while facilitating cross-regional collaboration.  Photo Download: http://bit.ly/4lBDJFAHKTDC Chairman Prof Frederick Ma meets with Chantawit Tantasith, Deputy Minister of Commerce of ThailandHKTDC Chairman Prof Frederick Ma meets with Dhanin Chearavanont, Senior Chairman of Charoen Pokphand GroupProf Frederick Ma, Chairman of HKTDC, discusses business resilience in Asia and promotes Hong Kong business advantages at the Singapore Regional Business Forum in BangkokPlease contact the HKTDC’s Communication & Public Affairs Department:Sam HoTel: (852) 2584 4569Email: sam.sy.ho@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Results Summary- Total revenue increased by 8% to HK$2,800 million, among which the revenue from Hong Kong increased by 9% to HK$1,600 million while the revenue from Mainland China increased by 9% to HK$700 million – both markets recorded growths- Revenue from the jewellery segment increased markedly by 13% to HK$1,100 million, among which gold products accounted for over 75% of the revenue from the jewellery segment- Gross profit rose by 8% to HK$800 million; gross profit margin remained resilient at 30.1%- Adjusted EBITD1 increased to HK$300 million and net profit rose by 5% to HK$200 million- As at 30 June 2025, bank balances and cash on hand amounted to over HK$1,500 million (31 December 2024: HK$950 million), without any bank borrowings and was in a net cash position, hence its net gearing ratio was zero, indicating a very healthy financial position- Successfully partnered with Mr. Chan Sai Cheong, strives to expand the jewellery business in Mainland China under “Emperor Jewellery”, and has already drawn up a preliminary roadmap for store expansions, with an initial target of 600 stores in Mainland China in the next five years; enables the jewellery business to become its future growth driver under the solid foundation of its watch business- Opened a Patek Philippe flagship store at a prime location in Central, Hong Kong, strengthening its market positionHONG KONG, Aug 20, 2025 - (ACN Newswire via SeaPRwire.com) - Emperor Watch & Jewellery Limited (“Group” or “Emperor W&J”) (Stock code: 887), a leading retailer of European-made watches and jewellery products, announced its interim results for the six months ended 30 June 2025 (“Period”).In spite of market uncertainties and challenging business environment, the Group’s total revenue grew by 7.6% to HK$2,794 million (2024: HK$2,597 million) during the Period. Revenue from Hong Kong increased by 8.8% to HK$1,594 million (2024: HK$1,465 million), accounting for 57.1% (2024: 56.4%) of the total revenue, and the revenue from Mainland China increased by 8.7% to HK$723 million (2024: HK$665 million), accounting for 25.9% (2024: 25.6%) of the total revenue. In terms of revenue by product segment, the revenue from the watch segment increased by 4.2% to HK$1,700 million (2024: HK$1,632 million), accounting for 60.8% (2024: 62.8%) of the total revenue, and the revenue from the jewellery segment increased markedly by 13.4% to HK$1,094 million (2024: HK$965 million), accounting for 39.2% (2024: 37.2%) of the total revenue, among which gold products accounted for 75.2% (2024: 77.0%) of the revenue from the jewellery segment.The Group’s gross profit increased by 7.7% to HK$840 million (2024: HK$780 million) with gross profit margin remained resilient at 30.1% (2024: 30.0%). The Group’s net profit increased by 4.9% to HK$194 million (2024: HK$185 million) during the Period. Basic earnings per share was HK2.73 cents (2024: HK2.72 cents). The Board declares an interim dividend of HK0.55 cent (2024: HK0.65 cent) per share.As at 30 June 2025, bank balances and cash on hand of the Group amounted to HK$1,508 million (31 December 2024: HK$950 million), without any bank borrowings (31 December 2024: zero) and was in a net cash position, hence its net gearing ratio was zero (31 December 2024: zero), indicating a healthy financial position.During the Period, the Group successfully partnered with Mr. Chan Sai Cheong (“Mr. Chan”), an influential and highly respected jewellery industry veteran with over 40 years of experience, regarding strategic development of the Group’s jewellery business in Mainland China. The Group has drawn up a preliminary roadmap for store expansions in Mainland China, with an initial target of 600 stores in the next five years, opening in phases. During the first phase, the focus will be on opening stores targeting mid-to-high-end market segments in established first-tier and new first-tier cities; this will be followed by an emphasis on stores in second-tier cities, targeting mid-market segment.As at 30 June 2025, the Group had a total of 73 stores in Hong Kong, Macau, Mainland China, Singapore and Malaysia. During the Period, the Group opened two new jewellery stores, in Hong Kong and Macau. Additionally, a Patek Philippe flagship store and a Tudor watch boutique were opened in Hong Kong and Chongqing in Mainland China, respectively. Subsequent to the Period, the Group opened a jewellery store in Hangzhou, Mainland China.Ms. Cindy Yeung, Chairperson of Emperor W&J, said, “With the ongoing pick-up in foot traffic after the resumption of the multiple-entry Individual Visit Scheme for Shenzhen permanent residents, and the tourism blueprint launched by the Hong Kong government, the Group is confident that the overall retail market will further regain its growth momentum. The Patek Philippe flagship store that was recently opened by the Group in Hong Kong will further enhance the Group’s competitive edge in the luxury watch retail market and strengthens its market leading position.”Ms. Yeung concluded, “The Group expects that gold jewellery, as an alternative form of investment, will continue being well received by Chinese consumers, given the volatile property and stock markets. The Group considers the establishment of the strategic partnership with Mr. Chan is a valuable opportunity for expanding its jewellery business in Mainland China. We will effectively expand its retail network footprint with diversified market segmentation strategies, thereby capturing a substantial share of the enormous opportunities in the Mainland China market.”Financial Highlights For the six months ended 30 JuneChanges2024HK$ million2025HK$ millionTotal revenue2,5972,794+ 7.6%Gross profit780840+ 7.7%Gross profit margin30.0%30.1%+ 0.1ppAdjusted EBITD [1]282297+ 5.3%Net profit185194+ 4.9%Basic earnings per shareHK2.72 centsHK2.73 cents+ 0.4%[1] Adjusted EBITD represents earnings before interest, tax and depreciation charge on the self-owned flagship store, which reflects the Group’s core operating performanceAbout Emperor Watch & Jewellery LimitedWith long establishment history of over 80 years in Hong Kong since 1942, Emperor W&J (887.HK) is a leading retailer principally engages in the sale of European-made internationally renowned watches, and jewellery products under its own brand, “Emperor Jewellery”. Through its comprehensive watch dealership, unique marketing campaigns and extensive retail network at prime locations in Hong Kong, Macau, Mainland China, Singapore and Malaysia, Emperor W&J established a strong brand image amongst its target customers ranging from middle to high income groups worldwide. In recognition of its efforts in investor relations communications, Emperor W&J was granted with “Best IR Company” (Small Cap), “Best IR Team” (Small Cap) and “Best Investor Presentation Material” (Small cap) in HKIRA Investor Relations Awards 2025 by the Hong Kong Investor Relations Association. For more information, please visit its website: www.EmperorWatchJewellery.com.Investor/Media EnquiriesAnna LukGroup Investor Relations DirectorTel: +852 2835 6783Email: annaluk@emperorgroup.comJanice AuGroup Investor Relations ManagerTel: +852 2835 6799Email: janiceau@emperorgroup.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

业绩摘要- 本期间的总收入上升8%至28亿港元，其中来自香港的收入上升9%至16亿港元，而来自中国内地的收入上升9%至7亿港元，两地均录得增长- 珠宝分部的收入显著上升13%至11亿港元，当中黄金产品占珠宝分部的收入超过7成半- 毛利增加8%至8亿港元；毛利率为30.1%，表现呈抗跌力- 经调整EBITD1上升至3亿港元，净利润增加5%至2亿港元- 于2025年6月30日，银行结余及手头现金为超过15亿港元(2024年12月31日：9.5亿港元)，没有任何银行借贷，并处于净现金状况，因此净负债比率为零，反映财务状况非常健康- 成功伙拍陈世昌先生，致力扩展「英皇珠宝」于中国内地之珠宝业务，并已拟定初步开店路线图，初期目标是于未来五年分阶段于中国内地开设600间店铺。在其具韧性的钟表业务基础上，务求珠宝业务成为未来增长动力- 于香港中环黄金地段开设了一间百达翡丽旗舰店，进一步巩固市场地位香港，2025年8月20日 - (亚太商讯 via SeaPRwire.com) - 欧洲制钟表及珠宝首饰之零售商翘楚－英皇钟表珠宝有限公司(「本集团」或「英皇钟表珠宝」)(股份编号：887)公布其截至2025年6月30日止六个月(「本期间」)之中期业绩。纵使市场存在不明朗因素及营商环境充满挑战，本集团于本期间的总收入增加7.6%至27.9亿港元(2024年：26.0亿港元)。来自香港的收入增加8.8%至15.9亿港元(2024年：14.7亿港元)，占总收入57.1%(2024年：56.4%)，而来自中国内地的收入增加8.7%至7.2亿港元(2024年：6.7亿港元)，占总收入25.9% (2024年：25.6%)。按产品分部划分的收入而言，钟表分部的收入上升4.2%至17.0亿港元(2024年：16.3亿港元)，占总收入60.8% (2024年：62.8%)，而珠宝分部的收入显著增加13.4%至10.9亿港元(2024年：9.7亿港元)，占总收入39.2% (2024年：37.2%)，当中黄金产品占珠宝分部的收入约75.2% (2024年：77.0%)。本集团的毛利增加7.7%至8.4亿港元(2024年：7.8亿港元)，毛利率为30.1% (2024年：30.0%)，表现呈抗跌力。本集团于本期间的净利润增加4.9%至1.94亿港元(2024年：1.85亿港元)。每股基本盈利为2.73港仙(2024年：2.72 港仙)。董事会宣派中期股息每股0.55港仙(2024年：0.65 港仙)。于2025年6月30日，本集团之银行结余及手头现金为15.1亿港元(2024年12月31日：9.5亿港元)，没有任何银行借贷(2024年12月31日：零)并处于净现金状况，因此净负债比率为零(2024年12月31日：零)，显示健康的财务状况。于本期间，本集团就其于中国内地珠宝业务之策略性发展成功伙拍陈世昌先生（「陈先生」）。陈先生为一位于珠宝行业具影响力且备受推崇的资深人士，拥有超过40年的经验。本集团已初步拟定于中国内地扩展店铺的路线图，初期目标是于未来五年分阶段开设600 间店铺。于第一阶段，开店的重点会落在成熟的一线城市及新一线城市，面向中高端市场；后续开店将侧重于二线城市，面向中端市场。于2025年6月30日，本集团于香港、澳门、中国内地、新加坡及马来西亚营运共73间店铺。于本期间，本集团于香港及澳门新开设两间珠宝店，另外亦分别于香港及中国内地重庆开设一间百达翡丽旗舰店及一间帝舵表钟表专卖店。本期间后，本集团于中国杭州开设一间珠宝店。英皇钟表珠宝主席杨諾思女士表示︰「随着深圳户籍居民一签多行个人游计划恢复后人流持续回升，加上香港政府推行的旅游业蓝图，本集团有信心整体零售市场将进一步重拾增长动力。本集团近期于香港开业的百达翡丽旗舰店，将进一步提升本集团于名贵钟表零售市场的竞争优势，并巩固其市场领先地位。」杨女士总结道︰「鉴于物业及股票市场波动，本集团预期作为另类投资的黄金珠宝将继续受中国消费者欢迎。本集团认为与陈先生建立战略合作伙伴关系，将为扩展其于中国内地之珠宝业务带来宝贵机会。我们将以多元化市场细分策略，有效地扩大其零售网络布局，从而在中国内地市场的庞大商机中抢占重大份额。」财务亮点 截至6月30日止六个月变动2024年百万港元2025年百万港元总收入2,5972,794+ 7.6%毛利780840+ 7.7%毛利率30.0%30.1%+ 0.1百份点经调整EBITD[1]282297+ 5.3%净利润185194+ 4.9%每股基本盈利2.72港仙2.73港仙+ 0.4%[1]经调整EBITD为利息、税项及自家拥有旗舰店的折旧费用前之盈利，以反映本集团之核心营运表现关于英皇钟表珠宝有限公司作为零售商翘楚，英皇钟表珠宝(887.HK)自1942年在香港开业至今已有超过80年悠久历史，业务包括销售享誉国际之欧洲制腕表及旗下「英皇珠宝」品牌之珠宝首饰。凭借其代理齐全的钟表品牌、独特的市场推广策略以及遍布香港、澳门、中国内地、新加坡及马来西亚黄金地段的广泛零售网络，英皇钟表珠宝在全球各地中高收入人士的目标顾客群中已建立稳固的品牌形象。于香港投资者关系协会颁发的2025年香港投资者关系大奖中，英皇钟表珠宝荣获「最佳投资者关系公司-小型股」、「最佳投资者关系团队-小型股」及「最佳投资者关系素材-小型股」。有关详细资料，请浏览其网站︰www.EmperorWatchJewellery.com。投资者/媒体查询陆文静集团投资者关系总监电话︰+852 2835 6783电邮：annaluk@emperorgroup.com区雪莹集团投资者关系经理电话电话︰+852 2835 6799电邮：janiceau@emperorgroup.com Copyright 2025 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com